Introduction
Leukaemia is a common cause of hypokalaemia in a hospital population (Lawson et al., 1979) . The pathogenesis of hypokalaemia is multifactoral and not completely understood. Five cases which demonstrate this multifactoral aetiology are presented.
Case histories No. I
A 48-year-old male with chronic lymphocytic leukaemia was admitted with fever, hypotension and tachycardia. Vital signs at admission were: BP 100/50 mmHg; pulse 115/min; respiration 22/min; temperature 402°0C; blood cultures were drawn and antibiotic therapy was initiated. This included cloxacillin sodium (1 g/6 hr), gentamicin sulphate (80 mg/8 hr) and ticarcillin sodium (3 g/4 hr). Figure  1 shows the serum and urine potassium values in chronological sequence. The (Sigler, 1975) . Vomiting and diarrhoea which are common complications of chemotherapy for malignant disease are associated with gastrointestinal losses of potassium. Except in gastric alkalosis, the urine potassium is generally less than 10 mmol/24 hr (Nardone, McDonald and Girard, 1978) .
Case 1 demonstrates the association of hypokalaemia with antibacterial antibiotic therapy. Hypokalaemia has been associated with massive intravenous doses of penicillin (Brunner and Frick, 1968) , carben,cillin (Lipner et al., 1975) and nafcillin (Mohr et al., 1979) . Patient no. 1 was receiving ticarcillin sodium. These antibiotics behave as nonreabsorbable anions. The potassium depletion in patients receiving these drugs can be attributed to the increased electrical negativity of the tubular lumen with subsequent enhancement of potassium secretion. A strong stimulus for distal sodium reabsorption is thought to be necessary for the non-permeant anion effect (Bank and Schwartz, 1960) . Gentamicin also increases urinary losses of potassium but the mechanism is unclear (Holmes, Hesling and Wilson, 1970) . Another type of antibiotic, amphotericin B, also causes hypokalaemia, but by a different mechanism. It is thought to be directly toxic to the distal tubular epithelium. This in some way alters cellular permeability and leads to excessive potassium loss (McCurdy, Frederic and Elkinton, 1968) . The association between lysozymuria and hypokalaemia is controversial (Muggia, Heinneman and Farhangi, 1969; Pickering and Catovsky, 1973; Mir, Brabin and Tang, 1975 The occurrence of concomitant hypokalaemia in the presence of hypercalcaemia in malignancy, as in the case of patient no. 4, has been reported previously (Aldinger and Samaan, 1977) . The mechanism involved is probably augmented renal losses of potassium (Sanderson, 1967 (Nardone et al., 1978) .
Hypokalaemia in the acute blast crisis of chronic granulocytic leukaemia, as in case of patient no. 5, has been reported previously (Yeung and Trowbridge, 1976) . Rapid cellular uptake of potassium by rapidly dividing cells as seen in the initiation of therapy of B12 deficiency anaemia (Lawson, Murray and Parker, 1972 ) is a probable factor. Treatment resulting in the resolution of the blast crisis would be expected to return the potassium to normal. It has also been postulated that antibiotic treatment would enhance the intracellular shift of potassium (Fisher, 1977) . Other work has suggested that inhibitory factors produced by leukaemic cells may impair Na/K transport in the renal tubule, resulting in hypokalaemia (Mir and Robinski, 1975) .
